Use of intravenous polymyxin B during continuous venovenous hemodialysis
J C Sarria1, F Angulo-Pernett, R C Kimbrough
1Department of Internal Medicine, Division of Infectious Diseases, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430 USA. juan.sarria@ttuhsc.edu
Abstract:
Described here is the case of a 23-year-old male with Acinetobacter baumannii sepsis and acute renal failure requiring continuous venovenous hemodialysis treated successfully with intravenous polymyxin B. The drug was administered as a loading dose of 2.5 mg/kg, followed by 2 doses of 1 mg/kg on days 4 and 8, then 0.8 mg/kg daily to complete a 24-day course. A discussion of dosing recommendations for polymyxins in dialysis is presented.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management


